JPMORGAN CHASE & CO - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 84 filers reported holding HUMACYTE INC in Q3 2023. The put-call ratio across all filers is 63.87 and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$180,474
+17.9%
61,595
+15.1%
0.00%
Q2 2023$153,085
-2.5%
53,526
+5.0%
0.00%
Q1 2023$157,000
+198634.2%
50,978
+36.7%
0.00%
Q4 2022$79
-99.9%
37,302
+112.9%
0.00%
Q3 2022$58,000
+23.4%
17,518
+20.1%
0.00%
Q2 2022$47,000
-47.2%
14,586
+16.2%
0.00%
Q1 2022$89,000
-15.2%
12,552
-12.8%
0.00%
Q4 2021$105,00014,3980.00%
Other shareholders
HUMACYTE INC shareholders Q3 2023
NameSharesValueWeighting ↓
Lion Point Capital, LP 235,000$688,5500.31%
Endowment Wealth Management, Inc. 97,518$285,7280.26%
Imprint Wealth LLC 47,072$137,9210.12%
Prescott General Partners LLC 568,246$1,664,9610.11%
GSA CAPITAL PARTNERS LLP 355,918$1,0430.09%
United Asset Strategies, Inc. 143,808$421,3570.05%
HAMILTON LANE ADVISORS LLC 21,893$64,1460.04%
Shay Capital LLC 65,110$190,7720.03%
CLOUGH CAPITAL PARTNERS L P 79,309$232,3750.02%
Powell Investment Advisors, LLC 12,000$35,1600.02%
View complete list of HUMACYTE INC shareholders